Sorrento Therapeutics, Inc. Indenture Agreements

5 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consent and Amendment No. 4 to Indenture among Scilex Pharmaceuticals, Sorrento Therapeutics, and U.S. Bank Trust Company
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2022
Consent and Amendment No. 3 to Indenture and Letter of Credit among Scilex Pharmaceuticals, Sorrento Therapeutics, U.S. Bank, and Noteholders
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Omnibus Amendment No. 2 to Indenture and Letter of Credit among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank National Association, and Noteholders
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Omnibus Amendment No. 1 to Indenture and Letter of Credit among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank National Association, and Noteholders
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Indenture Agreement for Senior Secured Notes due 2026 between Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., and U.S. Bank National Association
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2018